Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NOROVIN-CCM
- Development stage
- Unknown
- Lead developer
- Vin Medicament
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
NOROVIN-CCM is an oral fixed-dose combination product developed by Vin Medicament, primarily used as a nutritional supplement for bone health and the management of calcium deficiency. It contains Calcium Citrate Malate, Cholecalciferol (Vitamin D3), and Folic Acid. Calcium Citrate Malate provides a highly bioavailable form of elemental calcium necessary for bone mineralization and the maintenance of bone density. Cholecalciferol acts as an agonist at the Vitamin D receptor (VDR), facilitating the intestinal absorption of calcium and regulating phosphate levels. Folic acid is included to support cellular metabolism and overall health. Although categorized under analgesics and anti-inflammatories in commercial catalogs—likely due to its frequent prescription for bone-related pain and orthopedic conditions—it functions primarily as a mineral and vitamin supplement to prevent or treat conditions such as osteoporosis, osteomalacia, and hypocalcemia.
- Brand names
- NOROVIN-CCMNOROVIN-CCM CAPSULE
02
Targets
VDR (Vitamin D receptor)DHFR (Dihydrofolate reductase)
Beyond the preview
Go deeper on NOROVIN-CCM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NOROVIN-CCM.